EVALUATION OF LY2157299 MONOHYDRATE (LY), A TGF-β RECEPTOR I KINASE INHIBITOR, IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA: PHASE 2 STUDY RESULTS OF SAFETY, EFFICACY AND PK/PD

被引:5
作者
Giannelli, G. [1 ]
Faivre, S. [2 ]
Santoro, A. [3 ]
Kelley, R. K. [4 ]
Merle, P. [5 ]
Gane, E. [6 ]
Douillard, J. -Y. [7 ]
Waldschmidt, D. [8 ]
Mulcahy, M. [9 ]
Costentin, C. [10 ]
Minguez, B. [11 ]
Papappicco, P. P. [1 ]
Gueorguieva, I. [12 ]
Cleverly, A. [12 ]
Desaiah, D. [12 ]
Lahn, M. M. [12 ]
Ameryckx, S. [12 ]
Benhadji, K. A. [12 ]
Raymond, E. [2 ]
机构
[1] Univ Bari, Sch Med, Internal Med, Immunol,Infect Dis, Bari, Italy
[2] Hop Beaujon, Clichy, France
[3] Ist Clin Humanitas, Milan, Italy
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
[5] Hop Croix Rousse, F-69317 Lyon, France
[6] Auckland City Hosp, Auckland, New Zealand
[7] Ctr Rene Gauducheau, St Herblain, France
[8] Univ Klinikum Koln, Cologne, Germany
[9] Northwestern Univ, Chicago, IL 60611 USA
[10] Hosp Henri Mondor, Creteil, France
[11] Vall dHebron Hosp, Liver Unit, Med Oncol, Barcelona, Spain
[12] Eli Lilly & Co, Indianapolis, IN 46285 USA
关键词
D O I
10.1016/S0168-8278(14)60128-8
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
O126
引用
收藏
页码:S52 / S53
页数:2
相关论文
empty
未找到相关数据